Notice to Participate in PA-16-040 "Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21)"

Notice Number: NOT-AR-16-011

Key Dates
Release Date:   December 16, 2015

Related Announcements
PA-16-040    

Issued by
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Purpose

This Notice is to inform potential applicants that the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) will participate in the Funding Opportunity Announcement (FOA) PA-16-040 "Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21)". However, it is not the intent of NIAMS to support clinical trials through this FOA. Applicants who wish to submit clinical trials applications to the NIAMS are encouraged to utilize one of the NIAMS FOAs listed in "Policies and Guidelines for Investigator-Initiated Clinical Trials" on the NIAMS website.

The following sections have been updated to reflect the participation of NIAMS in this FOA:

Part 1. Overview Information

Components of Participating Organizations
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Cancer Institute (NCI)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute on Drug Abuse (NIDA)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.286; 93.121; 93.865; 93.853; 93.399; 93.396; 93.395; 93.394; 93.393; 93.279; 93.837; 93.846

Inquiries

Please direct all inquiries to:

Gayle E. Lester, Ph.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-594-3511
Email: lester1@mail.nih.gov